Medication info

Canidipine Tablet (Lercanidipine Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Lercanidipine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Youngil Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 200501922 · Notified 2005.01.13

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of mild to moderate essential hypertension
Who takes it
Adults
Adult dose
○ Adults Administer lercanidipine hydrochloride 5 ~ 10 mg orally once daily at least 15 minutes before a meal. The dose may be increased to 20 mg according to the patient's symptoms. Adjust the dose gradually, as it takes 2 weeks for the maximum antihypertensive effect to become clearly evident. Patients whose blood pressure is not controlled with this medicine may receive combination therapy with a beta-blocker (e.g., atenolol), a diuretic (e.g., hydrochlorothiazide), or an ACE inhibitor (e.g., captopril, enalapril). The dose-response curve is steep and reaches a plateau at doses of 20 ~ 30 mg; therefore, higher doses do not further increase efficacy and may instead increase adverse reactions. ○ Elderly patients: Pharmacokinetic data and clinical experience indicate that adjustment of the daily dose is not necessary; however, caution is required when initiating treatment in elderly patients. ○ Patients with hepatic or renal impairment: Special caution is required during initiation in patients with mild~moderate hepatic or renal impairment. Although the usual dosage pattern in these patients is consistent, caution is required when increasing the dose to 20 mg daily. In patients with hepatic impairment, the antihypertensive effect may be increased, so dose adjustment should be considered. Do not administer this medicine to patients with severe hepatic or renal impairment.

Ingredients

Manufacturer
Youngil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of mild to moderate essential hypertension

  • Essential hypertension
View approved original text

This medication is used to control blood pressure in patients with mild to moderate essential hypertension.

How to take

Adult dose

○ Adults Administer lercanidipine hydrochloride 5 ~ 10 mg orally once daily at least 15 minutes before a meal. The dose may be increased to 20 mg according to the patient's symptoms. Adjust the dose gradually, as it takes 2 weeks for the maximum antihypertensive effect to become clearly evident. Patients whose blood pressure is not controlled with this medicine may receive combination therapy with a beta-blocker (e.g., atenolol), a diuretic (e.g., hydrochlorothiazide), or an ACE inhibitor (e.g., captopril, enalapril). The dose-response curve is steep and reaches a plateau at doses of 20 ~ 30 mg; therefore, higher doses do not further increase efficacy and may instead increase adverse reactions. ○ Elderly patients: Pharmacokinetic data and clinical experience indicate that adjustment of the daily dose is not necessary; however, caution is required when initiating treatment in elderly patients. ○ Patients with hepatic or renal impairment: Special caution is required during initiation in patients with mild~moderate hepatic or renal impairment. Although the usual dosage pattern in these patients is consistent, caution is required when increasing the dose to 20 mg daily. In patients with hepatic impairment, the antihypertensive effect may be increased, so dose adjustment should be considered. Do not administer this medicine to patients with severe hepatic or renal impairment.

Precautions

This drug should not be used in certain patients. For example, it should not be administered to individuals with allergies to this drug or similar medications, pregnant or nursing women, patients with heart problems, individuals with severe liver or kidney disease, patients who have recently suffered a myocardial infarction, and children and adolescents under 18 years of age. Additionally, it should be administered with caution to patients with pacemaker issues, left ventricular dysfunction, ischemic heart disease, mild to moderate liver or kidney impairment, a history of angina pectoris, individuals who regularly consume alcohol, and the elderly. When taking this medication, symptoms such as facial flushing, swelling of hands and feet, rapid heartbeat, dizziness, headache, indigestion, vomiting, and liver dysfunction may occur. If symptoms are severe, consult a physician. Abruptly discontinuing the medication may worsen symptoms, so it should be tapered off gradually while monitoring the condition. Additionally, be cautious when driving or operating machinery due to the risk of dizziness or drowsiness. This medication is metabolized by the liver, so the effects of the drug may change when taken with certain medications. If you are taking other drugs, be sure to inform your physician or pharmacist. Pregnant or potentially pregnant women and nursing mothers should not take this medication, nor should it be used in children and adolescents. Older adults should exercise particular caution when starting this medication, and in the case of overdose, serious hypotension and cardiac issues may occur, necessitating immediate medical treatment. Lastly, this medication should be kept out of the reach of children and stored in its original container.

Side effects

  • Facial flushing
  • peripheral edema
  • palpitations
  • tachycardia
  • hypotension
  • chest pain
  • angina
  • headache
  • dizziness
  • asthenia
Show 29 more
  • fatigue
  • drowsiness
  • neurosis
  • dyspepsia
  • nausea
  • vomiting
  • abdominal pain
  • diarrhea
  • elevated serum aminotransferase levels
  • polyuria
  • frequent urination
  • gingival hyperplasia
  • rash
  • myalgia
  • tremor
  • insomnia
  • dry mouth
  • paresthesia
  • cough
  • abdominal distension
  • erectile dysfunction
  • arrhythmia
  • cold sweats
  • skin tingling
  • premature contractions
  • rigidity of the tongue
  • increased ventricular early contractions
  • dyspnea
  • gastrointestinal disorders

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.